Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease

Hyperphosphatemia is a risk factor for ectopic calcification and coronary artery diseases in end stage renal diseases (ESRD). The aim of this study was to assess the effect of low-dose nicotinic acid on hyperphosphatemia in patients with ESRD. This randomized, double-blind clinical trial was done on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahed, N. S., Zamanifar, N., Nikbakht, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964682/
https://www.ncbi.nlm.nih.gov/pubmed/27512294
http://dx.doi.org/10.4103/0971-4065.161020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964682/
https://www.ncbi.nlm.nih.gov/pubmed/27512294
http://dx.doi.org/10.4103/0971-4065.161020

Ejemplares similares